JAZZ News and Press, Jazz Pharmaceuticals plc From 12/20/23

Jazz Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference PR Newswire DUBLIN , Dec. 20, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will webcast its corporate presentation at the 42 nd...

2023-12-15 15:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-12-08 15:14:26 ET More on Jazz Pharmaceuticals Jazz Pharmaceuticals PLC (JAZZ) Q3 2023 Earnings Call Transcript Jazz Pharmaceuticals plc 2023 Q3 - Results - Earnings Call Presentation Jazz Pharma: Playing The High Notes With Xywav UBS lowers Jazz to neut...

Jazz Pharmaceuticals Presents Updated Phase 2a Data at SABCS 2023 Showcasing Potential of Zanidatamab in HER2+/HR+ Metastatic Breast Cancer PR Newswire First presentation of progression-free survival (PFS) primary endpoint data show zanidatamab plus palbociclib and fulvestrant...

NORTHAMPTON, MA / ACCESSWIRE / December 8, 2023 / Jazz Pharmaceuticals Originally Published in Jazz Pharmaceuticals' 2022 Corporate Sustainability and Social Impact Report Management Approach We aim to be an engaged corporate citizen globally and in our communities. We work through direct...

Jazz Pharmaceuticals to Present Long-Term and Real-World Data Emphasizing Commitment to Treatment-Resistant Epilepsy at the 2023 American Epilepsy Society Annual Meeting PR Newswire Data from nine abstracts to be presented, including real-world outcomes of Epidiolex ® ...

Jazz Pharmaceuticals to Present New Data Highlighting Advancements in Solid Tumors and Rare Blood Cancers at Upcoming Oncology Meetings PR Newswire New trial results of investigational bispecific antibody zanidatamab presented at SABCS in HER2+/HR+ metastatic breast cancer...

NORTHAMPTON, MA / ACCESSWIRE / November 29, 2023 / Jazz Pharmaceuticals Originally Published in Jazz Pharmaceuticals' 2022 Corporate Sustainability and Social Impact Report Management Approach We seek to operate our business in an environmentally responsible way and are committed to meeti...

2023-11-27 13:44:41 ET More on Jazz Pharmaceuticals Jazz Pharmaceuticals PLC (JAZZ) Q3 2023 Earnings Call Transcript Jazz Pharmaceuticals plc 2023 Q3 - Results - Earnings Call Presentation Jazz Pharma: Playing The High Notes With Xywav Jazz Pharma enters coll...

2023-11-16 20:59:03 ET Summary Baupost Group's 13F portfolio value decreased from $5.61B to $5.21B this quarter. The portfolio is heavily concentrated with Liberty Global, Liberty Media Sirius XM, Veritiv, Alphabet, and Fidelity National Information Services accounting for ~56% of...